Safety and Efficacy Pilot Study of AzaSite® for Four Weeks in Subjects With Blepharitis
NCT00656539
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Blepharitis
Interventions
DRUG:
AzaSite®
Sponsor
Merck Sharp & Dohme LLC